Company Overview and News

Image Resources’ $50m Boonanarring project fully funded

Image Resources’ Boonanarring zircon mineral sands project, around 80km north of Perth, is fully funded following satisfaction of a $50 million loan.

Sunrise secures $7m solar win

A commercial solar provider founded by former Western Power manager Neil Danby and olympic basketballer Andrew Vlahov has picked up its first contract, winning $7 million of work for Image Resources’ Boonanarring mineral sands project.

Image Resources to include solar farm at Boonanarring

Sunrise Energy Group will supply and construct a solar farm at Image Resources’ Boonanarring mineral sands project north of Perth in Western Australia.

Image launches $25m raising

Image Resources has launched a $25 million capital raising that will contribute to the construction of its Boonanarring mineral sands project near Gingin, which is targeting production by the end of the year.

Image launches $25 raising

Image Resources has launched a $25 million capital raising that will contribute to the construction of its Boonanarring mineral sands project near Gingin, which is targeting production by the end of the year.

Image Resources’ mineral sands project gathers steam as zircon prices rise

Image Resources NL (ASX:IMA) is finalising the award of a contract for constructing the site entry intersection for its zircon-rich Boonanarring Mineral Sands Project in the North Perth Basin.

Image Resources NL to lift cash balance for mineral sands

Image Resources NL (ASX:IMA) has been granted a trading halt by the ASX, pending details of a capital raising.

Image Resources NL expands mineral sands resource at Boonanarring

Image Resources NL (ASX:IMA) has reported a 39% increase in total ore reserves at its Boonanarring Mineral Sands Project located in the North Perth Basin.

Image Resources NL drilling extends high-grade zircon deposit

Image Resources NL (ASX:IMA) has confirmed a 5.6 kilometre extension of high-grade mineralisation from drilling at the Boonanarring mineral sands deposit located in the North Perth Basin.

Image Resources NL doubles heavy mineral resource at Boonanarring

The resource has been upgraded as part of the bankable feasibility study (BFS) for the company’s high-grade Boonanarring and Atlas mineral sand projects. When compared to the 2013 feasibility study, the total mineral resource has increased by 103% from 21.5 million to 43.7 million tonnes, albeit at a lower grade. The resource currently stands at 43.7 million tonnes at 5.6% total heavy minerals, at a cut-off grade of 2%.

Image Resources to raise $6.3M to advance mineral sands projects

The rights issue will be offered to eligible shareholders on the basis of five new shares for every 12 shares held on the record date. The funds raised will be used to: - Update the bankable feasibility study for the development of the Boonanarring and Atlas projects; - Purchase land critical to the development of Boonanarring; - Undertake additional exploration activities and for working capital purposes.

Investor Presentation


Results of Meeting


Shareholders Approve Transaction


Final Director's Interest Notice


Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

19h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...